Zimmer Biomet Q1 net earnings climb to USD 238.1 million; net sales rise 9.3% to USD 2.09 billion

Zimmer Biomet Holdings, Inc.

Zimmer Biomet Holdings, Inc.

ZBH

0.00
  • Zimmer Biomet posted net earnings of $238.1 million for the three months ended March 31, 2026.
  • Net sales climbed 9.3% to $2.09 billion.
  • Operating profit margin widened 2.6 percentage points to 17.9% of net sales.
  • Cash flows from operations eased to $359.4 million.
  • For 2026, net sales growth is expected at 2.5% to 4.5%.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zimmer Biomet Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-201710), on May 01, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.